A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung

Journal of Epidemiology

Volumn 12, Issue 3, 2002, Pages 258-265

  Ito, Hidemi ^a,b   Hamajima, Nobuyuki ^a   Takezaki, Toshiro ^a   Matsuo, Keitaro ^a,c   Tajima, Kazuo ^a   Hatooka, Shunzo ^a   Mitsudomi, Tetsuya ^a   Suyama, Motokazu ^a   Sato, Shigeki ^b   Ueda, Ryuzo ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Lung adenocarcinoma; OGG1 polymorphism; PCR CTPP

Indexed keywords

DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; GLYCOSIDASE;

ADENOCARCINOMA; AGED; ARTICLE; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; JAPAN; LUNG TUMOR; MALE; MIDDLE AGED; SMOKING;

ADENOCARCINOMA; AGED; CASE-CONTROL STUDIES; DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE; FEMALE; GENOTYPE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; N-GLYCOSYL HYDROLASES; POLYMORPHISM, GENETIC; SMOKING;

EID: 0036559490     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.12.258     Document Type: Article

References (40)

1. Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science, 1997; 278: 1043-1050.
2. Mamett LJ. Oxyradicals and DNA damage. Carcinogenesis, 2000; 21: 361-370.
3. Laval J, Jurado J, Saprabaev M, Sidorkina O. Antimutagenic role of base-excision repair enzymes upon free radical-induced DNA damage. Mutat Res, 1998; 402: 93-102.
4. Bohr VA, Dianov GL. Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie, 1999; 81: 155-160.
5. Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature, 1991; 349: 431-434.
6. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem, 1992; 267: 166-172.
7. Hussain SP, Harris CC. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res, 1998; 58: 4023-4037.
8. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science, 1991; 253: 49-53.
9. Jaruga P, Zastawny TH, Skokowski J, Dizdaroglu M, Olinski R. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett, 1994; 341: 59-64.
10. Kondo S, Toyokuni S, Iwasa Y et al. Persistent oxidative stress in human colorectal carcinoma, but not on adenoma. Free Radic Biol Med, 1999; 27: 401-410.
11. Musarrat J, Arezina-Wilson J, Wani AA. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer, 1996; 32A: 1209-1214.
12. van der Kemp PA, Thomas D, Barbey R, de Oliveira R, Boiteux S. Cloning and expression in Escherichia coli of the OGG1 gene of Saccharomyces cerevisiae, which codes for a DNA glycosylase that excises 7,8-dihydro-8-oxoguanine and 2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine. Proc Natl Acad Sci USA, 1996; 93: 5197-5202.
13. Nash HM, Bruner SD, Scharer OD et al. Cloning of a yeast 8-oxoguanine DNA glycosylase reveals the existence of a base-excision DNA-repair protein superfamily. Curr Biol, 1996; 6: 968-980.
14. Aburatani H, Hippo Y, Ishida T et al. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mu/M homologue. Cancer Res, 1997; 57: 2151-2156.
15. Arai K, Morishita K, Shinmura K et al. Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage. Oncogene, 1997; 14: 2857-2861.
16. Sakumi K, Furuichi M, Tsuzuki T et al. Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis. J Biol Chem, 1993; 268: 23524-23530.
17. Dianov G, Bischoff C, Piotrowski J, Bohr VA. Repair pathways for processing of 8-oxoguanine in DNA by mammalian cell extracts. J Biol Chem, 1998; 273: 33811-33816.
18. Ishida T, Takashima R, Fukayama M et al. New DNA polymorphisms of human MMH/OGG1 gene: prevalence of one polymorphism among lung-adenocarcinoma patients in Japanese. Int J Cancer, 1999; 80: 18-21.
19. Kohno T, Shimura K, Tosaka M et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene, 1998; 16: 3219-3225.
20. Sugimura H, Kohno T, Wakai K et al. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 1999; 8: 669-674.
21. Xing DY, Tan W, Song N, Lin DX. Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer, 2001; 95: 140-143.
22. Wikman H, Risch A, Klimel F et al. hOGGI polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a Caucasian population. Int J Cancer, 2000; 88: 932-937.
23. Hardie LJ, Briggs JA, Davidson LA et al. The effect of hOGG1 and glutathione peroxidase I genotypes and 3p chromosomal loss on 8-hidroxydeoxyguanosine levels in lung cancer. Carcinogenesis, 2000; 21: 167-172.
24. Dherin C, Radicella JP, Dizdaroglu M, Boiteux S. Excision of oxidatively damaged DNA bases by the human alpha-hOgg1 protein and the polymorphic alpha-hOgg1 (Ser326Cys) protein which is frequently found in human populations. Nucleic Acids Res, 1999; 27: 4001-4007.
25. Janssen K, Schlink K, Gotte W et al. DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutat Res, 2001; 486: 207-216.
26. Statistics and Information Department, Ministry of Health and Welfare. Vital statistics of Japan 1998, Vol 3, 2000. Health and Welfare Statistics Association, Tokyo, (in Japanese)
27. Sobue T, Ajiki W, Tsukuma H et al. Trends of lung cancer incidence by histologic type: a population-based study in Osaka, Japan. Jpn J Cancer Res, 1999; 90: 6-15.
28. Hamajima N, Matsuo K, Saito T et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res, 2001; 92: 383-389.
29. Hamajima N, Saito H, Matsuo K, Kozaki K, Takahashi T, Tajima K. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res., 2000; 91: 865-868.
30. Liu Q, Thorland EC, Heit JA, Sommer SS. Overlapping PCR for bidirectional PCR amplification of specific alleles: a rapid one-tube method for simultaneously differentiating homozygotes and heterozygotes. Genome Res, 1997; 7: 389-398.
31. Hamajima N, Matsuo K, Yuasa H. Adjustment of prognostic effects in prevalent case-control studies on genotype. J Epidemiol, 2001; 11: 204-210, Corrections, 228.
32. Sekine I, Nagai K, Tsugane S et al. Association between smoking and tumor progression in Japanese women with adenocarcinoma of the lung. Jpn J Cancer Res, 1999; 90: 129-135.
33. Hibi K, Takahashi T, Yamakawa K et al. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene, 1992; 7: 445-449.
34. Asami S, Hirano T, Yamaguchi R et al. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res, 1996; 56: 2546-2549.
35. Barbone F, Bovenzi M, Cavalleri F, Stanta G. Cigarette smoking and histologic type of lung cancer in men. Chest, 1997; 112: 1474-1479.
36. Kabet GC. Aspects of the epidemiology of the lung cancer in smokers and nonsmokers in the United States. Lung Cancer, 1996; 15: 1-20.
37. Wei Q, Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res, 1996; 56: 4103-4107.
38. Nakachi K, Hayashi S, Kawajiri K, Imai K. Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation. Carcinogenesis, 1995; 16: 2209-2213
39. Kawajiri K, Eguchi H, Nakachi K, Sekiya T, Yamamoto M. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res, 1996; 56: 72-76
40. Kumimoto H, Hamajima N, Nishizawa et al. Different susceptibility of each L-myc genotype to esophageal cancer risk factors. Jpn J Cancer Res, 2001; 92: 735-739.